What is a desmoid tumor? A desmoid tumor is a rare fibrous growth that can start in the arms, legs, or torso (body). They most commonly grow in the abdomen (belly). These tumors start in connective ...

The results of the DeFi trial of nirogacestat in 142 adults with progressing desmoid tumours showed a significant 71% improvement with the drug on progression-free survival (PFS) compared to ...

Diagnosed with a rare condition at age 18, Mackenzie Wilmoth has recovered, and she's leading the efforts to help those ...

Nansi was diagnosed with a desmoid-type fibromatosis (DF) - a rare type of intermediate soft tissue tumour, which sits somewhere between non-cancerous and cancerous. DF itself is not specifically ...

Two years later, Nansi, from Criccieth in Gwynedd, was diagnosed with desmoid-type fibromatosis (DF), a rare type of soft tissue tumour. "The doctors should have listened to me. I’m her mother ...

September 13, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it will present a ...

Pipeline Highlights Full enrollment for the Phase 3 RINGSIDE Part B study of AL102 for the treatment of desmoid tumors was completed in February 2024, and Immunome continues to expect to report ...

The stock got a huge boost in early February when Immunome announced plans to acquire desmoid tumor treatment candidate AL102 from Ayala Pharmaceuticals for $50 million. AL102 is a potential daily ...

J.P. Morgan analyst Anupam Rama maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report) today and set a price target ...